Merck ký cung cấp cho UNICEF 3 triệu liệu trình thuốc molnupiravir

(TTXVN/Vietnam+) 08:30 19/01/2022

Ngày 18/1, hãng dược Merck & Co Inc và đối tác Ridgeback Biotherapeutics thông báo đã ký một thỏa thuận với Quỹ Nhi đồng Liên hợp quốc (UNICEF) cung cấp cho cơ quan này 3 triệu liệu trình thuốc kháng virus molnupiravir điều trị bệnh COVID-19.

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